Merck ký cung cấp cho UNICEF 3 triệu liệu trình thuốc molnupiravir

(TTXVN/Vietnam+) 08:30 19/01/2022

Ngày 18/1, hãng dược Merck & Co Inc và đối tác Ridgeback Biotherapeutics thông báo đã ký một thỏa thuận với Quỹ Nhi đồng Liên hợp quốc (UNICEF) cung cấp cho cơ quan này 3 triệu liệu trình thuốc kháng virus molnupiravir điều trị bệnh COVID-19.

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